Merck ký cung cấp cho UNICEF 3 triệu liệu trình thuốc molnupiravir

(TTXVN/Vietnam+) 08:30 19/01/2022

Ngày 18/1, hãng dược Merck & Co Inc và đối tác Ridgeback Biotherapeutics thông báo đã ký một thỏa thuận với Quỹ Nhi đồng Liên hợp quốc (UNICEF) cung cấp cho cơ quan này 3 triệu liệu trình thuốc kháng virus molnupiravir điều trị bệnh COVID-19.

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